Merck ký cung cấp cho UNICEF 3 triệu liệu trình thuốc molnupiravir

(TTXVN/Vietnam+) 08:30 19/01/2022

Ngày 18/1, hãng dược Merck & Co Inc và đối tác Ridgeback Biotherapeutics thông báo đã ký một thỏa thuận với Quỹ Nhi đồng Liên hợp quốc (UNICEF) cung cấp cho cơ quan này 3 triệu liệu trình thuốc kháng virus molnupiravir điều trị bệnh COVID-19.

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